Literature DB >> 8288494

The post-antibiotic effect.

F M MacKenzie1, I M Gould.   

Abstract

Pharmacodynamics are being applied increasingly to the design of antibiotic dosing regimens. One characteristic of pharmacodynamics is the post-antibiotic effect (PAE), the delayed regrowth of bacteria following exposure to an antibiotic. In this review the various laboratory techniques which have been used to determine the PAE are critically evaluated and compared with the standard viable counting method. The potential sources of error associated with these methods are considered and recommendations are made for the optimum testing system; on the basis of current evidence the bioluminescence and impedence techniques appear to be the most suitable in terms of being the least labour-intensive and producing the most reliable results. Whichever technique is used, the properties of the growth medium, including osmolality and pH, the size of the bacterial inoculum, the initial antibiotic concentration, the exposure time to the antibiotic and the method of antibiotic removal should be standardized. Other post-(antibiotic) exposure events and their relationships with the PAE and theories concerning the mechanism (or mechanisms) by which antibiotics produce PAEs are discussed. Finally, consideration is given to the clinical significance of the PAE and how it, in conjunction with other pharmacodynamic parameters, might be used to allow antibiotic dosing regimens to be developed on a more scientific basis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288494     DOI: 10.1093/jac/32.4.519

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  55 in total

1.  Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.

Authors:  R Kumar; J K Malik
Journal:  Vet Res Commun       Date:  1998-12       Impact factor: 2.459

2.  Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains.

Authors:  A Novelli; S Fallani; M I Cassetta; S Conti; T Mazzei
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Expression of lux genes in a clinical isolate of Streptococcus pneumoniae: using bioluminescence to monitor gemifloxacin activity.

Authors:  S J Beard; V Salisbury; R J Lewis; J A Sharpe; A P MacGowan
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms.

Authors:  Amy E Kirby; Kimberly Garner; Bruce R Levin
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

5.  Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments.

Authors:  Bruce R Levin; Klas I Udekwu
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

6.  Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.

Authors:  K Fuursted
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

7.  Postantibiotic effect of DX-619 against 16 gram-positive organisms.

Authors:  G A Pankuch; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

8.  Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms.

Authors:  G A Pankuch; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

9.  Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.

Authors:  L Horgen; A Jerome; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.